Allogene Therapeutics, Inc. (ALLO)

NASDAQ: ALLO · Real-Time Price · USD

1.290

0.00 (0.00%)

At close: Jun 5, 2025, 4:00 PM

1.280

-0.010 (-0.78%)

After-hours: Jun 5, 2025, 5:02 PM EDT

Allogene Therapeutics Market Cap

Allogene Therapeutics has a market cap or net worth of $283.26 million as of June 5, 2025. Its market cap has decreased by -51.02% in one year.

Market Cap

283.26M

Enterprise Value

91.04M

1-Year Change

-51.02%

Ranking

#3401

Market Cap Chart

Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $283.26M, a decrease of -90.17%. That is a compound annual growth rate of -29.44%.

Market Cap History

Date	Market Cap	% Change
Jun 4, 2025	282.16M	-36.82%
Dec 31, 2024	446.60M	-17.32%
Dec 29, 2023	540.17M	-40.45%
Dec 30, 2022	907.08M	-57.34%
Dec 31, 2021	2.13B	-39.95%
Dec 31, 2020	3.54B	11.80%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	684.94B
Johnson & Johnson	368.90B
AbbVie	331.62B
Novo Nordisk	324.15B
UnitedHealth Group	270.36B
Abbott Laboratories	232.08B
Novartis AG	229.87B
AstraZeneca	226.47B

Market Cap Rankings